Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 501 - 550 out of 11,555

Document Document Title
WO/2015/150203A1
Cyclometallated Ir complex comprising three N,N diaryl substituted carbene ligands, bearing substituents in the 2 position of the non-cyclometallated aryl ring;an organic electronic device, preferably an organic light-emitting diode (OLE...  
WO/2015/149677A1
Described herein are novel platinum (II) emitters. These material show high emission quantum efficiency, low self‐quenching constant and stable in thermal deposition process. The OLED fabricated from these materials can have pure green...  
WO/2015/144759A1
The invention relates to prodrug compounds comprising a Co3+ ion and aquinazoline tyrosine kinase inhibitor moiety, wherein the quinazoline tyrosine kinase inhibitor moiety comprises a Co3+ -chelating moiety and wherein the quinazoline t...  
WO/2015/142684A1
The present invention relates to the compounds of formula (I), pharmaceutically acceptable salts, and solvates thereof, wherein the various substituents are as defined herein. The compounds, solvates and salts thereof of Formula (I) are ...  
WO/2015/141603A1
A metal complex indicated by general formula (1). (1) [In the formula, M indicates an iridium atom or a platinum atom, n1 indicates 1-3, n2 indicates 0-2, A1-G1-A2 indicates an anionic bidentate ligand, m1 and m2 indicate 3 or 4, E1-E4 i...  
WO/2015/142683A1
Newly synthesized thiourea-modified 3-chloro-4-fluoroanilio-quinazoline derivatives have been studied, as terminal carrier ligands in linear gold(I) complexes. The molecules mimic the tyrosine kinase inhibitor gefitinib (by computational...  
WO/2015/140337A1
The present invention relates to hybrid fumarate-CO-releasing molecules capable of increasing heme oxygenase-1 (HO-1) activity and HO-1 protein expression and simultaneously releasing CO, their synthesis and their use in therapeutic appl...  
WO/2015/139060A1
Described herein is the fusion of two families of unique carbon-containing molecules that readily disregard the tendency of carbon to form four chemical bonds, namely N-heterocyclic carbenes (NHCs) and carborane anions. Deprotonation of ...  
WO/2015/136913A1
 This method for producing a surface-modified substrate includes a step for bringing into contact, in the presence of a borane catalyst, a substrate having polar groups present on the surface thereof and a hydrosilane compound having a...  
WO/2015/137496A1
The present invention provides a process for efficiently producing an optically active 6-(3-aminopiperidin-1-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimi dine derivative. 1,4,5,6-tetrahydropyridine-3-carboxamide or a derivative thereof is asym...  
WO/2015/137194A1
 A neutral or cationic mononuclear ruthenium divalent complex represented by formula (1) can actualize exceptional catalytic activity in at least one reaction among a hydrosilylation reaction, hydrogenation reaction, and carbonyl compo...  
WO/2015/137272A1
The present invention provides a porous structure containing at least two kinds of metal ions and an organic ligand, said porous structure being characterized in that the at least two kinds of metal ions are homogeneously mixed together ...  
WO/2015/136845A1
Provided are a novel iridium complex and an organic EL element using the novel iridium complex. This iridium complex contains an Ir atom and a first ligand that is coordinated to the Ir atom and is represented by formula (L1). (In the fo...  
WO/2015/134663A1
Disclosed herein are processes for dehydrogenation of an alkane to an alkene using an iridium pincer complex. In the dehydrogenation reactions, hydrogen that is co-formed during the process must be removed for the chemical reaction to pr...  
WO/2015/130080A1
The present invention relates to a novel iridium (III) complex compound capable of being solution-processed and an organic electroluminescent device comprising same, and more specifically, to a novel iridium (III) complex compound into w...  
WO/2015/130780A1
There is provided a compound having Formula II In Formula II: R1- R4 are the same or different at each occurrence and can be D, alkyl, silyl, aryl, deuterated alkyl, deuterated silyl, or deuterated aryl; a and c are the same or different...  
WO/2015/131158A1
Chiral metal complexes having one of general formulae (1)-(4).  
WO/2015/129813A1
The present invention provides: a deuteration method that is both cost effective and has an excellent deuteration rate; a method for selectively replacing a leaving group of an aromatic compound with deuterium; and a deuteration catalyst...  
WO/2015/129994A1
The present invention relates to a novel red light-emitting iridium (III) complex compound capable of being solution-processed, and more specifically, to a novel iridium (III) complex compound into which a picolinic acid derivative is in...  
WO/2015/126400A1
Monocyclic N-pyridyl-1,4-azaborines and their Pt coordination complexes.  
WO/2015/127037A1
In some embodiments, the present disclosure pertains to a composition for modulating the expression of at least one gene associated with neuronal cell survival or stability. In some embodiments, the present disclosure provides for compos...  
WO/2015/089389A8
Pt(IV) prodrugs include one or more conjugated cyclooxygenase inhibitor. Reduction of Pt(IV) to Pt(II) can result cisplatin and a cyclooxygenase inhibitor. For proof of concept, a Pt(IV) prodrug that can produce cisplatin and aspirin, Pl...  
WO/2015/121150A1
The present invention relates to a water suspension of graphene oxide nanoflakes decorated by nanoparticles of metallic platinum, characterised in that it comprises: • 100μg/ml to 500μg/ml of graphene oxide nanoflakes, • 5μg/ml to...  
WO/2015/122502A1
The present invention pertains to a method for producing an optically active compound which includes a step for reducing an imino group of an imine compound or a step for reducing an unsaturated bond of a heterocyclic compound, while in ...  
WO/2015/117718A1
The invention relates to metal complexes and to electronic devices, in particular organic electroluminescence devices, containing said metal complexes.  
WO/2015/102020A4
The present invention relates to novel N-heterocyclic carbenes compounds and process of the preparation thereof. The present invention further relates to the use of use of these novel N-heterocyclic carbenes as ligand in the Suzuki-Miyau...  
WO/2015/118134A1
The present invention relates to platinum complexes with diazabicyclo- hydrocarbon compounds of the general formula (I), processes for preparing said complexes and the use thereof as pharmaceutically active compounds, in particular as cy...  
WO/2015/120391A1
The disclosure provides nanostructures (e.g., nanospheres and nano-paddlewheels) formed through transition metal-ligand (e.g., Pd(II)-, Ni(II)-, or Fe(II)-ligand of Formula (A)) coordination and junction self-assembly. The disclosure als...  
WO/2015/115937A1
The invention relates to the field of homogeneous catalysis and concerns the production of dicyclopentadiene metathesis polymerization catalysts. The present dicyclopentadiene polymerization catalyst in the form of a ruthenium complex is...  
WO/2015/115938A1
The invention relates to the field of homogeneous catalysis and concerns the production of a catalyst for the metathesis polymerization of dicyclopentadiene. A ruthenium catalyst for the polymerization of dicyclopentadiene consists of...  
WO/2015/115939A1
The invention relates to the field of catalysis and concerns the production of catalysts for the polymerization of dicyclopentadiene. A polymerization catalyst having general formula (I), where (II) is a fundamentally novel substituen...  
WO/2015/110515A1
A process for the hydrogenation of a substrate comprising a carbon heteroatom double bond in the presence of a transition metal complex comprising a tridentate or bisdentate- ligand containing a nitrogen, sulphur and phosphorus atom, of ...  
WO/2015/033313A3
The present disclosure relates to abnormal N-Heterocyclic Carbene complexes. The present disclosure also relates to synthesis, characterization and applications of abnormal N-Heterocyclic Carbene Complex.  
WO/2015/112561A1
Disclosed is a compound having Formula I: In Formula I: Ar is aryl or deuterated aryl; R1 and R2 are the same or different and can be alkyl, silyl, aryl, deuterated alkyl, deuterated silyl, or deuterated aryl; R3-R5 are the same or diffe...  
WO/2015/079207A3
The present invention relates to improved processes for the preparation of ruthenium or osmium complexes comprising P and N donor ligands, in particular, ruthenium complexes.  
WO/2015/105014A1
A metal complex which is represented by formula (1). (In the formula, M represents an iridium atom or a platinum atom; n1 represents 1, 2 or 3; n2 represents 0, 1 or 2; each of E1-E4 represents a nitrogen atom or a carbon atom; each of R...  
WO/2015/104045A1
The invention relates to metal complexes and to electronic devices, in particular organic electroluminescence devices, which contain said metal complexes.  
WO/2014/043243A3
The present disclosure relates to novel pharmaceutical compositions comprising a nanoparticle associated with, tether to, or encapsulating a platinum-based active pharmaceutical agent. The platinum-based drug is released from the nanopar...  
WO/2015/104961A1
The present invention relates to a raw material for a cyclometallized iridium complex, and provides a technique by which it is possible to obtain a cyclometallized iridium complex at a high yield at a lower reaction temperature than in a...  
WO/2015/102922A1
The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one carboxylate or carbamate ligand.  
WO/2015/102020A1
The present invention relates to novel N-heterocyclic carbenes compounds and process of the preparation thereof. The present invention further relates to the use of use of these novel N-heterocyclic carbenes as ligand in the Suzuki-Miyau...  
WO/2015/102928A1
The present teachings relate to platinum-based compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex having at least one polar moiety as a ligand. In some embodiments,...  
WO/2015/099507A1
The present disclosure relates to an organic electroluminescent compound, and a multi-component host material and an organic electroluminescent device comprising the same. The organic electroluminescent compound of the present disclosure...  
WO/2015/092112A1
The invention relates to a metalorganic polymeric system which coordinates highly stable particles having functional groups on the surface that can act as anchoring points for different species which have properties such as luminescence,...  
WO/2015/093177A1
The present invention provides a ruthenium compound (a precursor) which can be used in a chemical vapor deposition method, particularly an ALD method, and which has good reactivity with a reactive gas, a high vapor pressure and a low mel...  
WO/2015/091158A1
The present invention relates to the field of catalytic hydrogenation and, more particularly, to the use of Fe complexes with tridentate ligands, having one amino or imino coordinating group and two phosphino coordinating groups, in hydr...  
WO/2015/087739A1
The present invention addresses the problem of providing an organic electroluminescence (EL) element for which the light-emission maximum wavelength is shorter, the light-emission lifetime is long, the drive voltage is low, the change ov...  
WO/2015/086400A1
The present invention relates to cationic alkali metal compounds of neutral transition metal complexes, to methods for producing same and to the use thereof in optoelectronic components.  
WO/2015/088867A2
Use a solvent blend that contains 1-methoxy-2,7-octadiene and an alkanols rather than the alkanols by itself to prepare a catalyst precursor suitable for use in butadiene telomerization.  
WO/2015/087062A1
The present application is directed towards complexes of formula (I), to methods for preparing such complexes, and to use of such complexes in catalysis. The complexes show utility in a range of catalytic cycles, including Pd(ll)/Pd(IV) ...  

Matches 501 - 550 out of 11,555